Skip to main content
SpringerLink
Log in

Progestogen content of oral contraceptives singled out in VTE

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Lokkegaard E.Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9 BMJ 343: [15 pages], 25 Oct 2011. Available from: URL: http://dx.doi.org/10.1136/bmj.d6423

  2. Hannaford PC.The progestogen content of combined oral contraceptives and venous thromboembolic risk. BMJ 343: [2 pages], 25 Oct 2011. Available from: URL: http://dx.doi.org/10.1136/bmj.d6592

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Progestogen content of oral contraceptives singled out in VTE. React. Wkly. 1376, 3 (2011). https://doi.org/10.2165/00128415-201113760-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113760-00006

Keywords

Search

Navigation